In the media - President comments on psychedelics in mental health

02 September 2020

RANZCP President, Associate Professor John Allan, has commented on Mind Medicine Australia's submission to the Therapeutic Goods Administration to allow psychiatrists to use MDMA and the hallucinogenic psilocybin in therapy sessions.

Read full article: Regulator weighs push to legalise MDMA for mental health treatment